These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20717825)

  • 1. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.
    van den Esschert JW; Bieze M; Beuers UH; van Gulik TM; Bennink RJ
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):436-40. PubMed ID: 20717825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
    Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
    Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
    van den Esschert JW; van Gulik TM; Phoa SS
    Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
    Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A
    Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
    Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
    BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focal nodular hyperplasia and hepatocellular adenoma].
    Bastati-Huber N; Pötter-Lang S; Ba-Ssalamah A
    Radiologe; 2015 Jan; 55(1):18-26. PubMed ID: 25575723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
    Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A
    Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia.
    Bieze M; Busch OR; Tanis PJ; Verheij J; Phoa SS; Gouma DJ; van Gulik TM
    HPB (Oxford); 2014 Feb; 16(2):140-9. PubMed ID: 23509949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
    Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F
    Clin Nucl Med; 2009 Oct; 34(10):659-65. PubMed ID: 19893396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
    Nougaret S; Monsonis B; Molinari N; Riviere B; Piron L; Kassam Z; Cassinotto C; Guiu B
    Eur Radiol; 2020 Sep; 30(9):4752-4761. PubMed ID: 32318848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
    Bröker MEE; Taimr P; de Vries M; Braun LMM; de Man RA; Ijzermans JNM; Dwarkasing RS
    AJR Am J Roentgenol; 2020 Jan; 214(1):81-89. PubMed ID: 31573852
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.